Month: August 2018

Two partner projects @CITY and @CITY-AF aim to develop concepts, technologies and prototype applications to enable automated driving in complex urban areas

Die Forschungsinitiative @CITY führt 15 Partner aus Automobilwirtschaft, Zulieferindustrie, Software-Entwicklung und Univer sitäten zusammen. Untergliedert in die zwei Projekte @CITY und @CITY-AF werden Konzepte, Technologien und prototypische Anwendungen entwickelt, die das automatisierte Fahren in komplexen urbanen Räumen ermöglichen sollen. Ziel ist es, den Stadtverkehr der Zukunft für alle Verkehrsteilnehmer möglichst sicher, komfortabel und effizient zu

Novartis announces EC approval for Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for adjuvant treatment of BRAF V600 mutation-positive melanoma

Approval based on COMBI-AD study demonstrating greater than 50% reduction in risk of disease recurrence or death in stage III melanoma patients   More than 50% of stage III melanoma patients are likely to recur to stage IV during their lifetime EC approval marks third indication in Europe for leading BRAF/MEK inhibitor combination Tafinlar + Mekinist

Alcon announces an immediate, voluntary market withdrawal of the CyPass Micro-Stent from the global market

Decision based on five-year data from COMPASS-XT long-term safety study Alcon advises ophthalmic surgeons to cease further implantation BASEL, 31-Aug-2018 — /EuropaWire/ — Reflecting its uncompromising commitment to patient safety, Alcon today announced an immediate, voluntary market withdrawal of the CyPass Micro-Stent from the global market. In addition, Alcon advises surgeons to immediately cease further implantation with the CyPass

University of Glasgow physicists part of groundbreaking new measurement of the Higgs boson from the ATLAS Collaboration at CERN’s Large Hadron Collider (LHC)

University of Glasgow physicists part of groundbreaking new measurement of the Higgs boson from the ATLAS Collaboration at CERN’s Large Hadron Collider (LHC) GLASGOW, 31-Aug-2018 — /EuropaWire/ — For the second time this summer, University of Glasgow physicists are celebrating a groundbreaking new measurement of the Higgs boson from the ATLAS Collaboration at CERN’s Large Hadron

Audio recordings of the traditions of crofters, farm workers and fishermen, in English and Gaelic put online by the University of Glasgow

Audio recordings of the traditions of crofters, farm workers and fishermen, in English and Gaelic put online by the University of Glasgow Tasglann èisteachd Gàidhlig/Beurla Oilthigh Ghlaschu ri fhaotainn saor ’s an-asgaidh GLASGOW, 31-Aug-2018 — /EuropaWire/ — Their songs and stories speak of a different time. Living memories passed down from parent to child over generations.

Philips on AI and adaptive intelligence in healthcare

AMSTERDAM, 31-Aug-2018 — /EuropaWire/ — At a time when health systems and healthcare professionals are under more pressure than ever to do more with less, the promise of intelligent technology that can deliver life-changing insights from all our data is enticing. Will it help to fill the deficit of around 13 million skilled health professionals

Royal Philips to acquire US-based scale-up company developing and commercializing next-generation sensor technologies

Royal Philips to acquire US-based scale-up company developing and commercializing next-generation sensor technologies AMSTERDAM, 31-Aug-2018 — /EuropaWire/ —  Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired Xhale Assurance Inc, a US-based scale-up company developing and commercializing next-generation sensor technologies. Xhale Assurance’s unique, disposable pulse oximetry sensor is

Royal Philips: the European Society of Cardiology to incorporate instantaneous wave-free ratio (iFR) into its updated revascularization guidelines

iFR is an innovative pressure-derived index unique to Philips. iFR-guided strategy now deemed beneficial in the assessment of the functional significance of intermediate coronary stenosis  Technique using iFR-guided strategy is non-inferior to FFR for guiding decisions for intervening on immediate lesions with stable angina or NSTE ACS MUNICH, 31-Aug-2018 — /EuropaWire/ — Royal Philips (NYSE: PHG, AEX: